Cargando…
187. Risk Factors and Outcomes of Patients with Serratia Bacteremia at an Academic Medical Center
BACKGROUND: The majority of reported Serratia infective endocarditis (SIE) in recent years are healthcare-associated. At our urban institution with a high prevalence of people who inject drugs (PWID), we noted an increasing number of Serratia bacteremias (SB) and SIE over the past decade. Our study...
Autores principales: | Doktor, Katherine L, King, Madeline, Martirosyan, Diana, Moore, Scott R, Fraimow, Henry S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676963/ http://dx.doi.org/10.1093/ofid/ofad500.260 |
Ejemplares similares
-
256. Serratia Marcescens Bacteremia and Endocarditis: A Treatment Assessment from an Academic Medical Center
por: Slain, Douglas, et al.
Publicado: (2020) -
187. Vancomycin Plus Ceftaroline Salvage Therapy for Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Kufel, Wesley D, et al.
Publicado: (2021) -
187. The 30-Day Readmission and 30-Day Mortality of Hemodialysis Patients with Antibiotic-Resistant Gram-Negative Bacteremia
por: Oommen, Jomi K, et al.
Publicado: (2019) -
244. Impact of Antibiotic Susceptibility Reporting on Broad-Spectrum Antibiotic Use in Serratia and Morganella Bacteremia
por: Wen Ng, Wendy Hui, et al.
Publicado: (2018) -
Uncomplicated Staphylococcus aureus Bacteremia Treatment Duration and Outcomes at an Academic Medical Center
por: Taupin, Daniel, et al.
Publicado: (2020)